EUVIMEDEUVIMED entdecken
Open Access

TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities

Shiyuan Guo, Tianyu Qi, Yinsheng Wang iD

Journal of Proteome Research · 2025

DOI: 10.1021/acs.jproteome.5c00805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Shiyuan Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genetics, Genomics and Bioinformatics Graduate Program, University of California, Riverside, California 92521-0403, United States. Hauptthemen laut MEDLINE: Vemurafenib, Melanoma, Drug Resistance, Neoplasm, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VemurafenibMelanomaDrug Resistance, NeoplasmMitochondriaMitochondrial ProteinsHumansCell Line, TumorGene Expression Regulation, NeoplasticProto-Oncogene Proteins B-raf

Stichwörter der Autor:innen

drug resistanceepitranscriptomicsmelanomaparallel-reaction monitoringtRNAtargeted proteomics

Substanzen

VemurafenibMitochondrial ProteinsProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Genetics, Genomics and Bioinformatics Graduate Program, University of California, Riverside, California 92521-0403, United States.
  • Environmental Toxicology Graduate Program, University of California, Riverside, California 92521-0403, United States.
  • Department of Chemistry, University of California, Riverside, California 92521-0403, United States.

ORCID-Profile: Yinsheng Wang

Förderung

  • NIEHS NIH HHS
  • National Institute of Environmental Health Sciences

Zitieren

APA

Guo, S., Qi, T., & Wang, Y. (2025). TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00805

Vancouver

Guo S, Qi T, Wang Y. TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00805

BibTeX
@article{Guo2025,
  author = {Guo, Shiyuan and Qi, Tianyu and Wang, Yinsheng},
  title = {TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities},
  journal = {Journal of Proteome Research},
  year = {2025},
  doi = {10.1021/acs.jproteome.5c00805}
}
Kostenlos starten →